Search Results - "Petito, V"

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide by Mele, M. C., Gaetani, E., Petito, V., Cammarota, G., Marzetti, Emanuele, Martone, Anna Maria, Landi, Francesco, Gasbarrini, Antonio, Miggiano, G., Mentella, M., Sicignano, L. L., Ingravalle, F., Musca, T., Lopetuso, L., Pizzoferrato, M., Scaldaferri, Franco, Graziani, C.

“…Malnutrition is a major complication of inflammatory bowel disease (IBD). This mini review is focusing on main determinants of malnutrition in IBD, the most…”
Get full text

The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors by Lopetuso, L R, Scaldaferri, F, Bruno, G, Petito, V, Franceschi, F, Gasbarrini, A

“…Gut barrier is a functional unit organized as a multi-layer system and its multiple functions are crucial for maintaining gut homeostasis. Numerous scientific…”
Get more information

P.03.12: Breath Methane Production in Lactulose Breath Test is Affected by Gender, a Post HOC Italian Study by Tesori, V, Petito, V, Graziani, C, Scaldaferri, F, Gasbarrini, A

Get full text

Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis by Scaldaferri, F, Pecere, S, Petito, V, Zambrano, D, Fiore, L, Lopetuso, L.R, Schiavoni, E, Bruno, G, Gerardi, V, Laterza, L, Pizzoferrato, M, Ianiro, G, Stojanovic, J, Poscia, A, Papa, A, Sterbini, F.P, Sanguinetti, M, Masucci, L, Cammarota, G, Gasbarrini, A

“…Abstract Background Inflammatory bowel disease (IBD) is the results of a chronic inflammatory process deriving from disequilibrium between self-microbiota…”
Get full text

Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment by Ponziani, F R, Scaldaferri, F, De Siena, M, Mangiola, F, Matteo, M V, Pecere, S, Petito, V, Sterbini, F Paroni, Lopetuso, L R, Masucci, L, Cammarota, G, Sanguinetti, M, Gasbarrini, A

“…Compositional and functional alterations of the gut microbiota are involved in the pathogenesis of several gastrointestinal diseases. Rifaximin is often used…”
Get more information

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease by Lopetuso, L R, Petito, V, Zambrano, D, Orlando, D, Dal Lago, A, Serrichhio, L, Papa, A, Gasbarrini, A, Scaldaferri, F

“…Mucosal healing (MH) represents a crucial factor for maintaining gut homeostasis. Indeed, in inflammatory bowel disease, MH has become the standard…”
Get more information

P.05.8: Clausii in Colitis: Role and Mechanisms of Action of Bacillus Clausii in Experimental Colitis by Scaldaferri, F, Graziani, C, Petito, V, Lopetuso, L, Quaranta, G, Sanguinetti, M, Masucci, L, Franceschi, F, Poscia, A, Arena, V, Scannone, D, Ianiro, G, Cammarota, G, Sgambato, A, Gasbarrini, A

Get full text

OC.14.6: Escherichia Coli Nissle 1917 Modulate GUT Microbiota Composition in Ulcerative Colitis Patients by Graziani, C, Petito, V, Del Chierico, F, Mangiola, F, Pecere, S, Schiavoni, E, Pizzoferrato, M, Lopetuso, L, Putignani, L, Gasbarrini, A, Scaldaferri, F

Get full text

P.05.9: Colitis is Associated with Muscle Function Alteration: Emerging Mechanisms of Asthenia in IBD? by Petito, V, Graziani, C, Lopetuso, L, Pizzoferrato, M, Ingravalle, F, Schiavoni, E, Pani, G, Sgambato, A, Cammarota, G, Gasbarrini, A, Scaldaferri, F

Get full text

First steps towards understanding the dynamic evolution of gut microbiota in different stages of liver disease by Ponziani, F.R, Pecere, S, Sterbini, F. Paroni, Petito, V, Siciliano, M, Di Rienzo, T, Palladini, A, Zambrano, D, Franceschi, F, Gaetani, E, Scaldaferri, F, Masucci, L, Sanguinetti, M, Gasbarrini, A

Get full text

P.09.15 INCREASED ABUNDANCE OF BENEFICIAL BACTERIA IS ASSOCIATED WITH CLINICAL IMPROVEMENT AFTER RIFAXIMIN TREATMENT by Ponzani, F.R, Scaldaferri, F, Pecere, S, Paroni Sterbini, F, Petito, V, Lopetuso, L.R, Gerardi, V, Palladini, A, Graziani, C, Masucci, L, Pompili, M, Sanguinetti, M, Gasbarrini, A

Get full text

P.01.9 THE GUT MICROBIOTA OF CIRRHOTIC PATIENTS WITH POOR NUTRITIONAL STATUS: PRELIMINARY EVIDENCES by Ponzani, F.R, Pecere, S, Petito, V, Paroni Sterbini, F, Tortora, A, Annichiarico, B.E, Siciliano, M, Palladini, A, Graziani, C, Masucci, L, Pompili, M, Sanguinetti, M, Gasbarrini, A

Get full text

P.07.1 GUT MICROBIOTA MOLECULAR SPECTRUM IN HEALTHY CONTROLS, DIVERTICULAR DISEASE, IBS AND IBD PATIENTS: TIME FOR MICROBIAL MARKER OF GASTROINTESTINAL DISORDERS? by Lopetuso, L.R, Petito, V, Schiavoni, E, Zambrano, D, Paroni Sterbini, F, Gaetani, E, Franceschi, F, Cammarota, G, Sanguinetti, M, Masucci, L, Scaldaferri, F, Gasbarrini, A

Get full text

The gut microbiota of cirrhotic patients with poor nutritional status: Preliminary evidences by Ponziani, F.R, Pecere, S, Petito, V, Sterbini, F.P, Tortora, A, Annicchiarico, B.E, Siciliano, M, Palladini, A, Graziani, C, Masucci, L, Pompili, M, Sanguinetti, M, Gasbarrini, A

Get full text

Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication by Scaldaferri, F, Nardone, O, Lopetuso, L R, Petito, V, Bibbò, S, Laterza, L, Gerardi, V, Bruno, G, Scoleri, I, Diroma, A, Sgambato, A, Gaetani, E, Cammarota, G, Gasbarrini, A

“…Intestinal gases are the expression of metabolic activity of gut microbiota in the gut, particularly carbohydrates in the case of H2, CH4. Alterations in…”
Get more information

Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives by Scaldaferri, F., Petito, V., Lopetuso, L., Bruno, Giovanni, Gerardi, V., Ianiro, G., Sgambato, A., Gasbarrini, Antonio, Cammarota, Giovanni

“…Inflammatory bowel disease (IBD) is a chronic inflammatory condition characterized by an abnormal immune response against food or bacterial antigens in…”
Get full text

OC.16.4 DIRECT ROLE OF INFLIXIMAB ON INTESTINAL MUCOSA SUSTAINS MUCOSAL HEALING: EXPLORING NEW MECHANISMS OF ACTION by Petito, V, Scaldaferri, F, Lopetuso, L.R, Stigliano, E, Arena, V, Bibbo', S, Amato, A, Cammarota, G, Sgambato, A, Gasbarrini, A

Get full text

P.06.9 INFLIXIMAB IS NOT INCREASING COLONIC CANCER RISK ASSOCIATED TO CHRONIC COLITIS IN MICE by Scaldaferri, F, Lopetuso, L.R, Petito, V, Bruno, G, Gerardi, V, Cufino, V, Arena, V, Stigliano, E, Caristio, M, Poscia, A, Cammarota, G, Papa, A, Sgambato, A, Gasbarrini, A

Get full text

OC.07.6 GELENTERUM AMELIORATES SEVERITY OF COLITIS IN DSS MURINE MODEL, WHILE MODULATING GUT MICROBIOTA AND INTESTINAL MUCUS LAYER by Scaldaferri, F, Lopetuso, L.R, Petito, V, Gerardi, V, Bilotta, M, Papi, M, Maolucci, G, Stigliano, E, Cufino, V, Arena, V, De Logu, G, Sanguinetti, M, De Spirito, M, Sgambato, A, Gasbarrini, A

Get full text

P.03.1 INFLIXIMAB (IFX) ACTS LOCALLY ON INTESTINAL MUCOSA AND ITS PHARMACOKINETIC IS DIFFERENT IN DSS COLITIC MICE COMPARED TO CONTROLS by Scaldaferri, F, Lopetuso, L.R, Petito, V, Gerardi, V, Arena, V, Stigliano, E, Papa, A, Cufino, V, Amato, A, Cammarota, G, Gaetani, E, Sgambato, A, Gasbarrini, A

Get full text